Babak Azad - Mar 8, 2023 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role
Chief Marketing Officer and SVP, Marketing & Communications
Signature
/s/ Gracye Cheng, as Attorney-in-Fact for Babak Azad
Stock symbol
GDRX
Transactions as of
Mar 8, 2023
Transactions value $
-$44,490
Form type
4
Date filed
3/9/2023, 05:31 PM
Previous filing
Dec 12, 2022
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GDRX Class A Common Stock Options Exercise +20.4K +111.21% 38.7K Mar 8, 2023 Direct F1
transaction GDRX Class A Common Stock Tax liability -$44.5K -8.09K -20.88% $5.50 30.7K Mar 8, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Restricted Stock Unit Options Exercise $0 -20.4K -6.67% $0.00 286K Mar 8, 2023 Class A Common Stock 20.4K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximtely equal quarterly installments thereafter for 15 quarters.

Remarks:

Chief Marketing Officer and SVP, Marketing & Communications